NDC 70261-522

Tim-Brim-Dor-Lat

Timolol - Brimonidine - Dorzolamide - Latanoprost

Tim-Brim-Dor-Lat is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimisrx Nj. The primary component is Dorzolamide Hydrochloride; Brimonidine Tartrate; Latanoprost; Timolol Maleate.

• Product ID: 70261-522_6bb5e498-b278-191a-e053-2a91aa0acab3
• NDC: 70261-522
• Product Type: Human Prescription Drug
• Proprietary Name: Tim-Brim-Dor-Lat
• Generic Name: Timolol - Brimonidine - Dorzolamide - Latanoprost
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2018-01-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: ImprimisRx NJ
• Substance Name: DORZOLAMIDE HYDROCHLORIDE; BRIMONIDINE TARTRATE; LATANOPROST; TIMOLOL MALEATE
• Active Ingredient Strength: 20 mg/mL; mg/mL; mg/mL; mg/mL
• Pharm Classes: Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Prostaglandin Analog [EPC],Prostaglandins [CS],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 70261-522-05

5 mL in 1 BOTTLE, DROPPER (70261-522-05)

• Marketing Start Date: 2018-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70261-522-05 [70261052205]

Tim-Brim-Dor-Lat SOLUTION/ DROPS

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
DORZOLAMIDE HYDROCHLORIDE	20 mg/mL

OpenFDA Data

• SPL SET ID: 6ba4f0b3-d776-3485-e053-2991aa0abab3
• Manufacturer:
  • ImprimisRx NJ
• UNII:
  • 4S9CL2DY2H
  • QZO5366EW7
  • 6Z5B6HVF6O
  • P8Y54F701R
• PHarm Class EPC:
  • Prostaglandin Analog [EPC]
• NUI Code:
  • N0000175454
  • N0000007706

Pharmacological Class

• Carbonic Anhydrase Inhibitor [EPC]
• Carbonic Anhydrase Inhibitors [MoA]
• Adrenergic alpha-Agonists [MoA]
• alpha-Adrenergic Agonist [EPC]
• Prostaglandin Analog [EPC]
• Prostaglandins [Chemical/Ingredient]
• Adrenergic beta-Antagonists [MoA]
• beta-Adrenergic Blocker [EPC]
• Prostaglandins [CS]